Categories
-
Adhesives
6
Amines
115
Amino Acids
208
Analytical Reagents
724
Antibiotics
271
Bioactive Small Molecules
796
Aroma Chemicals
250
Biochemicals
1138
Boronic Acids
4
Buffers
103
Building Blocks
2190
Carbohydrates
195
Catalysts
120
Chiral Compounds
75
Detergents
64
Diagnostic Raw Materials
262
Equipment
3
Flavours and Fragrance Materials
239
Fluorinated Products
68
Furans
7
Gases in Solution
56
Grignard Reagents
32
HPLC Reagents
7
Imidazoles
19
Indoles
48
Inorganic Chemicals
363
Ligands
79
Organics
1622
Oxazoles
3
Peptide Reagents
101
Phenols
55
Picolines
0
Piperazines
13
Pyrazines
3
Pyridines
69
Pyrimidines
36
Quaternary Ammonium salts
44
Reagents
113
Research Organics & Inorganics
875
Salts
312
Sealing Compounds
1
Sherclin
1
Solvents
130
Stains & Indicators
320
Sugars
67
Testing Standards
4
Uncategorised
0
Water Analysis
10
Arecoline hydrobromide
(11161105 | 300-08-3)
| CAS: | 300-08-3 |
|---|---|
| Molecular Formula: | C8H13NO2 · HBr |
| Molecular Weight: | 236.11 |
| Availablility: | Inquire for Status |
|---|---|
| Downloads: | Product Specification | Safety Data Sheet [EN] |
| 11161105-25g | 25g | £100.80 | |
| Bulk Order | |||
| 11161105-25g | 25g | €151.20 | |
| Bulk Order | |||
| 11161105-25g | 25g | $161.30 | |
| Bulk Order | |||
Safety Data Sheet
Certificate of Analysis
Product Detail
| Product Code | 11161105 | ||||
| Product Name | Arecoline hydrobromide | ||||
| Categories | Antibiotics Bioactive Small Molecules Biochemicals Research Organics & Inorganics | ||||
| CAS | 300-08-3 | ||||
| Molecular Formula | C8H13NO2 · HBr | ||||
| Molecular Weight | 236.11 | ||||
| Storage Details | Ambient | ||||
| Harmonised Tariff Code | 29397990 |
Product Specification
| Melting Point | 171 - 173 Deg C | ||||
| Heavy metals | <10ppm | ||||
| Identification | GC-MS | ||||
| Loss on Drying | <0.5% | ||||
| Solution | Clear and Transparent | ||||
| Appearance | White crystalline powder | ||||
| Assay (dry basis) | 98 - 100% |
Safety Information
| Pictograms |
|
||||
| Signal word | warning | ||||
| Hazard statements |
|
||||
| Precautionary statements |
|